The design and synthesis of compounds targeted against human immunodeficiency virus 1 (HIV-1) protease have resulted in effective antiviral therapies. However, the rapid replication of the virus and the inherent mutability of the viral genome result in the outgrowth of resistant strains in the major
Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere
β Scribed by Yoshiaki Kiso
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1996
- Tongue
- English
- Weight
- 759 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
β¦ Synopsis
Peptidomimetic Human
The human immunodeficiency virus (HIV) codas f o r an u.spartic protease known to be essential $)r retroviral mat urution and replicution. The H I V proteuw can rmignize Phe-Pro and Tyr-Pro sequences as the virus-specific cleuvuge site. These.fi.atures provided a basisJor the rational design of selective HI Vprotease-lurgeted drugs,fi)r the treatment ofacquired immunod&iency syndrome (AIDS). HIV protouse is ,formed,Jrom two identical 99 amino acid peptides. I.I/L. replaced the two Cys residues by L-AIU to .synthesizr [Aho7." ] -HIV-1 protease by the solid 1 protease (NY-5 isolate) using the thioester chemical ligation method. Based on the .substrate transition state, we designed and synthesizeda novel cla.ss ofHI Vproteuse inhibitors containing an unnatural amino acid, ( 2 S , 3s) -3-amino-2-hydrox.v-4-phcnylbu~yuic acid, named allophenylnorstutine (Apns) with a hydrox.vmethyIcarbonyl (HMC) isosterc. Among them, the conformationally constrained tripeptide kynostutin ( K N I ) -272 (iQou-Mtu-Apns-Thz-NHBu') was a highly selective and superpotent HI Vprotease inhibitor (Ki = 0.0055 nM). KNI-272 exhibited potent antiviral activities against both AZT-sensitive and -insensitive clinical HIV-1 isolates as well us HIV-2 with low cytotoxicity. Ajer i.d. administration, bioavailability qf KNI-272 was 42.3% in rats. Also, KNI-272 exhibited in vivo anti-HIV activities in human PBMC-SCID mice. The x-ray crystallography and molecular modeling studies showed that the HMC group in KNI-272 interacted excellently wilh the aspartic acid carboxyl groiips of HIVproteuse active site in the essentially same hydrogen-bonding mode us the trunsition state. This result implies that the H M C isostere is an ideal transition-stutc mimic and contrihtes to the high activity of phase method and then preparcd [ Tyro.4', Nle36,46, (NHCH2c'OSc'H2CO)-~'-~~, AIU'~.~' 1 H I v-
π SIMILAR VOLUMES